https://moximed.com/news/moximed-raises-40-million-to-advance-worlds-first-implantable-shock-absorber-for-knee-osteoarthritis/ 2022-08-30T20:21:51+00:00 https://moximed.com/news/moximeds-misha-knee-system-achieves-superiority-of-primary-endpoint-in-pivotal-study/ 2022-09-22T20:20:58+00:00 https://moximed.com/news/peer-reviewed-publication-shows-superiority-of-moximeds-misha-knee-system/ 2023-03-25T03:38:58+00:00 https://moximed.com/news/fda-authorizes-marketing-of-misha-knee-system-for-people-suffering-from-knee-osteoarthritis/ 2023-04-11T00:01:27+00:00 https://moximed.com/news/favorable-five-year-survivorship-of-implantable-shock-absorber-and-reduction-of-arthroplasty-risk-in-high-risk-patients-reported-in-peer-reviewed-publications/ 2023-05-23T13:13:13+00:00 https://moximed.com/news/moximeds-misha-knee-system-treats-first-commercial-patients-in-united-states/ 2023-09-06T12:15:30+00:00 https://moximed.com/news/moximed-announces-appointment-of-dave-amerson-to-board-of-directors/ 2024-01-04T13:58:35+00:00 https://moximed.com/news/james-leech-joins-moximed-as-chief-financial-and-strategy-officer/ 2024-01-18T16:30:09+00:00 https://moximed.com/news/moximed-inc-names-christopher-gleason-as-chief-executive-officer/ 2024-06-25T13:08:08+00:00 https://moximed.com/news/moximed-completes-closing-of-series-d-financing-for-91-million-to-accelerate-commercialization-of-misha-knee-system-an-implantable-shock-absorber-for-knee-osteoarthritis/ 2024-08-13T12:03:53+00:00 https://moximed.com/news/robert-spomer-joins-moximed-as-senior-vice-president-of-sales/ 2024-08-20T17:44:52+00:00 https://moximed.com/news/michael-mydra-joins-moximed-as-senior-vice-president-of-reimbursement-and-market-access/ 2024-10-10T15:58:35+00:00 https://moximed.com/news/cms-grants-new-procedure-code-for-the-misha-knee-system/ 2025-03-04T22:26:53+00:00 https://moximed.com/wp-content/uploads/2025/02/MISHA-Knee-System.png https://moximed.com/news/brian-donovan-joins-moximed-as-chief-operating-officer/ 2025-04-10T12:42:36+00:00 https://moximed.com/news/first-patients-treated-in-a-new-randomized-controlled-trial-evaluating-the-misha-knee-system-vs-non-surgical-treatment-for-knee-osteoarthritis/ 2025-05-29T12:06:05+00:00 https://moximed.com/wp-content/uploads/2025/05/motion_rct_logo.png